患有心力衰竭的患者的主观认知问题:综合性审查
Catherine M Martin1, Elham Y Algashgari2, Yvonne Lu3
1Catherine M. Martin, MSN, RN, Indiana University School of Nursing, Indianapolis.
The Journal of cardiovascular nursing
|February 6, 2026
概括
主观认知问题在心力衰竭 (HF) 患者中很常见,影响高达91%. 这些问题与HF严重程度,心理困扰和影响生活质量相关,突出了针对性干预的需要.
科学领域:
- 心脏病学 心脏病学
- 神经学 神经学
- 心理学 心理学 心理学
背景情况:
- 认知功能障碍是心力衰竭 (HF) 患者的常见问题.
- 主观认知问题 (SCC) 是个人对自己的认知能力的担忧,这些担忧可能与客观评估不同.
- 人们对SCC在HF群体中的患病率和影响知之甚少.
研究的目的:
- 确定HF患者中SCC的患病率和严重程度.
- 为了确定影响HF患者SCC的因素.
- 探索与高频中SCC相关的结果.
主要方法:
- 使用CINAHL,PubMed,PsycINFO和EMBASE进行了整合性的文献审查.
- 搜索组合了与心力衰竭和主观认知问题相关的关键词.
- 该综述包括了9篇文章,包括来自567名HF患者的数据.
主要成果:
- 在HF患者中,SCC的患病率在40%至91%之间,重度轻度至中度.
- 影响SCC的因素包括HF严重程度,心理困扰 (抑郁,焦虑,压力),多病症 (COPD,失眠,高BMI) 和较差的客观认知功能.
- SCC与降低生活质量,减少参与有意义的活动以及增加自我护理努力有关.
结论:
- 主观认知问题非常普遍,在心力衰竭患者中具有轻度至中度的严重程度.
- 识别影响SCC的因素可以帮助确定有风险的个体.
- 了解SCC结果可以指导干预措施,以改善HF患者的健康状况.
更多相关视频
03:47Author Spotlight: Workflow for Integrating POCUS Data into EHR for Managing Heart Failure Patients
Published on: July 12, 2024
1.2K
04:05Author Spotlight: Unveiling Prognostic Indicators in Heart Failure - The Role of Phase Angle and Bioelectrical Impedance Analysis
Published on: June 30, 2023
2.9K
相关概念视频
Heart Failure II: Pathophysiology
964
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
964
Pathophysiology of Heart Failure
3.8K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
3.8K
Heart Failure I: Introduction
903
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
903
Heart Failure VI: Adjunct Therapies
348
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
348
Heart Failure Drugs: Diuretics
987
Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
987
Heart Failure V: Medical Management
330
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
330
